DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $189,165 | -32.4% | 13,435 | -25.8% | 0.00% | 0.0% |
| Q1 2023 | $279,923 | +37.9% | 18,118 | +65.2% | 0.00% | 0.0% |
| Q3 2022 | $203,000 | +41.0% | 10,970 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $144,000 | +46.9% | 10,970 | +3.7% | 0.00% | – |
| Q1 2022 | $98,000 | -72.9% | 10,580 | +31.0% | 0.00% | -100.0% |
| Q1 2021 | $362,000 | -49.8% | 8,075 | -36.1% | 0.00% | -33.3% |
| Q4 2020 | $721,000 | +14.6% | 12,641 | +3.1% | 0.00% | 0.0% |
| Q3 2020 | $629,000 | +153.6% | 12,261 | +195.4% | 0.00% | +200.0% |
| Q2 2020 | $248,000 | – | 4,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |